Comparing the current results to its competitors, Dynatronics reported Revenue decrease in the 1 quarter 2025 year on year by -7.61 %, despite the revenue increase by the most of its competitors of 8.01 %, recorded in the same quarter.
Dynatronics Corporation, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 4.29 %
Dynatronics's Comment on Competition and Industry Peers
Dynatronics operates in a fragmented industry with numerous competitors of varying sizes, including personal care companies, branded consumer healthcare companies, and private label manufacturers. The company does not face a single competitor across all product lines. In the soft bracing products segment, competitors are primarily regional manufacturers and several large corporations. In the treatment tables, exercise and rehabilitation equipment, and related supplies segments, competitors include several domestic and international manufacturers and distributors. In the clinical market for therapeutic modality devices, Dynatronics competes with both domestic and foreign companies. Some of Dynatronics' products are protected by patents or proprietary technology.
Axogen Inc is a medical technology company specializing in the development and commercialization of products for peripheral nerve reconstruction. Their business model focuses on providing innovative solutions to surgeons and patients by offering a comprehensive portfolio of nerve repair technologies and services. Through partnerships with healthcare providers, Axogen aims to enhance patient outcomes and improve the quality of life for those suffering from peripheral nerve injuries.
Conmed Corporation operates as a global medical technology company that develops, manufactures, and markets surgical devices and equipment for minimally invasive procedures.
Integra Lifesciences Holdings Corp's business model revolves around developing, manufacturing, and selling medical devices and instruments to healthcare providers.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Stryker Corps business model focuses on innovation in medical technologies and devices, specializing in areas such as orthopedics, surgical equipment, and neurotechnology, to enhance patient care and improve outcomes in the healthcare industry.
Sources:
Dynatronics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Dynatronics Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
